Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bordignon

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Cancer Immunology, Immunotherapy : CII|August 14, 2016
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing miceClaudia Lanterna, Andrea Musumeci, Laura Raccosta, et al.
Human Gene Therapy Methods|June 18, 2013
RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapyAnna Stornaiuolo, Bianca Maria Piovani, Sergio Bossi, et al.
Frontiers in Immunology|April 6, 2018
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide GeneMonica Casucci, Laura Falcone, Barbara Camisa, et al.
Clinical & Experimental Metastasis|February 5, 2015
Anti-metastatic activity of the tumor vascular targeting agent NGR-TNFPaola Di Matteo, Patrizia Mangia, Elena Tiziano, et al.
Molecular Therapy. Methods & Clinical Development|May 9, 2017
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T LymphocytesClaudia Piovan, Virna Marin, Cinzia Scavullo, et al.
Journal of Leukocyte Biology|June 3, 2008
Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivoEduardo J Villablanca, Dan Zhou, Barbara Valentinis, et al.
Cancer Research|November 16, 2012
De novo design of a tumor-penetrating peptideLuca Alberici, Lise Roth, Kazuki N Sugahara, et al.
The Journal of Clinical Investigation|September 22, 2007
Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunityVincenzo Russo, Arcadi Cipponi, Laura Raccosta, et al.
Blood|May 3, 2011
IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectorsAttilio Bondanza, Lothar Hambach, Zohara Aghai, et al.
Molecular Therapy. Methods & Clinical Development|May 26, 2016
RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelopeVirna Marin, Anna Stornaiuolo, Claudia Piovan, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|August 14, 2016
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing miceClaudia Lanterna, Andrea Musumeci, Laura Raccosta, et al.
Human Gene Therapy Methods|June 18, 2013
RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapyAnna Stornaiuolo, Bianca Maria Piovani, Sergio Bossi, et al.
Frontiers in Immunology|April 6, 2018
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide GeneMonica Casucci, Laura Falcone, Barbara Camisa, et al.
Clinical & Experimental Metastasis|February 5, 2015
Anti-metastatic activity of the tumor vascular targeting agent NGR-TNFPaola Di Matteo, Patrizia Mangia, Elena Tiziano, et al.
Molecular Therapy. Methods & Clinical Development|May 9, 2017
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T LymphocytesClaudia Piovan, Virna Marin, Cinzia Scavullo, et al.
Journal of Leukocyte Biology|June 3, 2008
Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivoEduardo J Villablanca, Dan Zhou, Barbara Valentinis, et al.
Cancer Research|November 16, 2012
De novo design of a tumor-penetrating peptideLuca Alberici, Lise Roth, Kazuki N Sugahara, et al.
The Journal of Clinical Investigation|September 22, 2007
Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunityVincenzo Russo, Arcadi Cipponi, Laura Raccosta, et al.
Blood|May 3, 2011
IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectorsAttilio Bondanza, Lothar Hambach, Zohara Aghai, et al.
Molecular Therapy. Methods & Clinical Development|May 26, 2016
RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelopeVirna Marin, Anna Stornaiuolo, Claudia Piovan, et al.
Pageof 10